Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs AASHKA HOSPITALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS AASHKA HOSPITALS KRSNAA DIAGNOSTICS/
AASHKA HOSPITALS
 
P/E (TTM) x - - - View Chart
P/BV x 10.5 5.3 198.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   AASHKA HOSPITALS
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
AASHKA HOSPITALS
Mar-21
KRSNAA DIAGNOSTICS/
AASHKA HOSPITALS
5-Yr Chart
Click to enlarge
High RsNANA-   
Low RsNANA-   
Sales per share (Unadj.) Rs998.822.6 4,418.6%  
Earnings per share (Unadj.) Rs284.52.3 12,448.0%  
Cash flow per share (Unadj.) Rs342.13.7 9,163.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NMNM- 
Book value per share (Unadj.) Rs355.516.2 2,187.7%  
Shares outstanding (eoy) m6.5018.00 36.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x00-   
Avg P/E ratio x00-  
P/CF ratio (eoy) x00-  
Price / Book Value ratio x00-  
Dividend payout %00-   
Avg Mkt Cap Rs m00-   
No. of employees `000NANA-   
Total wages/salary Rs m29647 630.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,492407 1,595.6%  
Other income Rs m1220 305,900.0%   
Total revenues Rs m6,615407 1,625.6%   
Gross profit Rs m3,46699 3,496.7%  
Depreciation Rs m37426 1,436.6%   
Interest Rs m25932 811.9%   
Profit before tax Rs m2,95541 7,181.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1050-   
Profit after tax Rs m1,84941 4,495.1%  
Gross profit margin %53.424.4 219.1%  
Effective tax rate %37.40-   
Net profit margin %28.510.1 281.7%  
BALANCE SHEET DATA
Current assets Rs m2,481152 1,629.7%   
Current liabilities Rs m1,838150 1,222.2%   
Net working cap to sales %9.90.5 2,160.7%  
Current ratio x1.41.0 133.3%  
Inventory Days Days253 761.5%  
Debtors Days Days41656 6.2%  
Net fixed assets Rs m3,564499 714.8%   
Share capital Rs m2,489180 1,382.7%   
"Free" reserves Rs m-178112 -158.6%   
Net worth Rs m2,310292 790.0%   
Long term debt Rs m1,680202 833.1%   
Total assets Rs m6,045651 928.9%  
Interest coverage x12.42.3 541.6%   
Debt to equity ratio x0.70.7 105.5%  
Sales to assets ratio x1.10.6 171.8%   
Return on assets %34.911.2 310.6%  
Return on equity %80.014.1 569.0%  
Return on capital %80.514.8 544.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1,026145 707.2%  
From Investments Rs m-611-80 766.4%  
From Financial Activity Rs m308-80 -387.1%  
Net Cashflow Rs m723-14 -5,014.5%  

Share Holding

Indian Promoters % 27.4 61.3 44.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 38.7 187.6%  
Shareholders   75,554 2,771 2,726.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    DR. LAL PATHLABS    MAX HEALTHCARE INSTITUTE    



Today's Market

Indian Indices End Flat Amid Volatility; Asian Paints, Axis Bank & HUL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 14, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 5-YR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS